Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer
NCT ID: NCT00957606
Last Updated: 2011-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
100 participants
INTERVENTIONAL
2009-08-31
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* to determine the rate of osteoporosis among patients with advanced prostate cancer.
* to propose an algorithm for early detection of patients with advanced prostate cancer who are at risk of developing osteoporosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation
NCT00124410
Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
NCT00199537
Strategies to Improve Bone Health in Men on ADT
NCT02043236
Healthy Bones Study
NCT01973673
Bone Health Observational Study
NCT00632905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients are followed for 2 years after inclusion with blood sampling, DXA-scan, questionnaire, bone scintigraphy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sampling, DXA-scan, bone scintigraphy
Blood sampling 5 times DXA-scan 5 times Bone scintigraphy 3 times
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Initiation of androgen deprivation therapy
* Oral and written informed consent
Exclusion Criteria
* Treatment for osteoporosis within the last year
* Other malignancy
* Other bone disease, bedbound, use of steroid
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zealand University Hospital
OTHER
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Urology, Odense University Hospital, Denmark
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mads H Poulsen, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Urology, Odense University Hospital, Denmark
Steen Walter, MD, DMSci, Professor
Role: STUDY_CHAIR
Department of Urology, Odense University Hospital, Denmark
Morten MF Nielsen, MD
Role: STUDY_CHAIR
Department of Endocrinology, Odense University Hospital, Denmark
Kim Brixen, MD, PhD, Professor
Role: STUDY_CHAIR
Department of Endocrinology, Odense University Hospital, Denmark
Claus Dahl, MD
Role: STUDY_CHAIR
Department of Urology, Roskilde Hospital, Denmark
Peter Eskildsen, MD, DMSci
Role: STUDY_CHAIR
Department of Endocrinology, Køge Hospital, Denmark
Oke Gerke, PhD
Role: STUDY_CHAIR
University of Southern Denmark
Bo Abrahamsen, MD, PhD, Professor
Role: STUDY_CHAIR
Faculty of Health Sciences, University of Southern Denmark, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Urology, Odense University Hospital
Odense, , Denmark
Department of Urology, Roskilde Hospital
Roskilde, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Steen Walter, MD, DMSci, Professor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Steen Walter
Role: backup
Claus Dahl, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-20080004
Identifier Type: -
Identifier Source: secondary_id
PCa & Osteoporosis 09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.